Ridostro

Ridostro Injection injection comes as a solution (liquid) to be injected intravenously (into a vein) by a doctor or a nurse in a clinical setting or hospital. During the initial stage of treatment, Ridostro Injection is usually given once a day for the first 14 days of a 28-day cycle. After the first cycle, it is given once a day for the first 10 days of a 28-day cycle. Your doctor will decide how often you are to receive Ridostro Injection based on your body's response to this medication.

The early symptoms of ALS include muscle twitches in the arm, leg, shoulder, or tongue, muscle cramps, tight and stiff muscles (spasticity), muscle weakness affecting an arm, leg, neck, or diaphragm, as well as slurred and nasal speech and difficulty chewing or swallowing. For many individuals, the first sign of ALS may appear in the hand or arm as they experience difficulty with simple tasks such as buttoning a shirt, writing, or turning a key in a lock. In other cases, symptoms initially affect one of the legs, and people experience awkwardness when walking or running or notice that they are tripping or stumbling more often.

There are no studies to support whether ALS can be prevented or not. However, one can reduce the possibility of acquiring the disease by knowing various risk factors. The risk factors associated with ALS include smoking and exposure to pesticides and insecticides. In addition to that, another report suggests that people who have served in the military can also have a high risk of developing ALS.

Ridostro Injection cannot cure ALS, but it may help slow the progression of the disease. It works by reducing oxidative stress, which is thought to contribute to nerve cell damage in ALS. However, it does not stop or reverse the disease, and its effectiveness varies among patients.

Caucasians and non-Hispanics are most likely to develop the disease. About 5 to 10% of all ALS cases are familial, which means that an individual inherits the disease from his or her parents. ALS can strike at any age; symptoms most commonly develop between the ages of 55 and 75. It is slightly more likely to develop in men than in women. However, as we age, the difference between men and women disappears. Furthermore, some studies suggest that military veterans are about 1.5 to 2 times more likely to develop ALS because of toxin exposure during warfare.

Researchers have suggested that exposure to toxins during warfare or strenuous physical activity is a possible reason why some veterans and athletes may be at increased risk of developing ALS.

Ridostro Injection is used as a neuroprotective agent to help reduce brain damage caused by an ischemic stroke. It works by neutralizing harmful free radicals and reducing oxidative stress, which can damage brain cells during and after a stroke.

Ridostro Injection is most effective when started as early as possible, ideally within 24 to 72 hours of the onset of stroke symptoms. Early administration helps protect nerve cells and may improve recovery outcomes. Always follow your doctor’s guidance for timing and dosage.

Inform your doctor or pharmacist if you are allergic to edaravone, any other medications, sodium bisulfite, or any of the ingredients in Ridostro Injection. If you are taking or planning to take any other prescription and nonprescription medications, vitamins, and nutritional supplements, inform your doctor beforehand. Your doctor may need to change the doses of your medications or monitor you carefully for side effects. Tell your doctor if you have or have ever had asthma or if you are pregnant, planning to conceive, or breastfeeding. If you become pregnant while receiving edaravone, consult your doctor.